Hostname: page-component-cd9895bd7-fscjk Total loading time: 0 Render date: 2024-12-28T07:18:08.423Z Has data issue: false hasContentIssue false
  • English
  • Français

The Efficacy and Safety of 28-day Treatment with Ziprasidone in Schizophrenia/schizoaffective Disorder

Published online by Cambridge University Press:  16 April 2020

E. Harrigan  and
Ziprasidone Working Group
E. Harrigan
Affiliation:
Department of Clinical Research, Pfizer Central Research, GrotonCT 06340, USA

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Poster Presentations
Information
European Psychiatry , Volume 11 , Issue S4: European psychiatry: a force for the future - 8th Congress of Association of European Psychiatrists and Annual Meeting of the Royal College of Psychiatrists , 1996 , pp. 412s
Copyright
Copyright © Elsevier Paris 1996
Submit a response

Comments

No Comments have been published for this article.